{"id":28934,"date":"2021-08-03T15:32:35","date_gmt":"2021-08-03T21:32:35","guid":{"rendered":"http:\/\/bambapolitica.com.mx\/?p=28934"},"modified":"2021-08-03T15:32:48","modified_gmt":"2021-08-03T21:32:48","slug":"farmaco-baricitinib-de-lilly-reduce-riesgo-de-muerte-en-pacientes-intubados","status":"publish","type":"post","link":"https:\/\/bambapolitica.com.mx\/index.php\/2021\/08\/03\/farmaco-baricitinib-de-lilly-reduce-riesgo-de-muerte-en-pacientes-intubados\/","title":{"rendered":"F\u00e1rmaco baricitinib de Lilly reduce riesgo de muerte en pacientes intubados"},"content":{"rendered":"\n<p class=\"has-medium-font-size\">Eli Lilly and Co&nbsp;y su&nbsp;socio Incyte Corp&nbsp;dijeron este martes que resultados adicionales de un&nbsp;estudio&nbsp;en&nbsp;etapa avanzada&nbsp;mostraron que su&nbsp;producto baricitinib&nbsp;redujo el&nbsp;riesgo de muerte&nbsp;en&nbsp;pacientes&nbsp;con&nbsp;covid-19&nbsp;en&nbsp;respiradores artificiales.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">La&nbsp;Administraci\u00f3n de Alimentos y Medicamentos de Estados Unidos&nbsp;(FDA) aprob\u00f3 por primera vez a&nbsp;baricitinib&nbsp;-medicamento para la&nbsp;artritis- de&nbsp;Lilly&nbsp;combinado con&nbsp;remdesivir&nbsp;de&nbsp;Gilead Sciences&nbsp;para tratar a los&nbsp;pacientes&nbsp;con&nbsp;covid-19.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">El mes pasado, la FDA ampli\u00f3 la autorizaci\u00f3n del medicamento para uso individual o con remdesivir.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Los datos m\u00e1s recientes de 101 pacientes en el estudio de Lilly\/Incyte muestran que los pacientes en respiraci\u00f3n artificial&nbsp;que recibieron baricitinib m\u00e1s atenci\u00f3n est\u00e1ndar ten\u00edan un 46% menos de probabilidades de morir, en comparaci\u00f3n con los pacientes que recibieron placebo m\u00e1s atenci\u00f3n est\u00e1ndar.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Lilly dijo que los nuevos datos del estudio se compartir\u00e1n con las autoridades de Estados Unidos, la Uni\u00f3n Europea y otras geograf\u00edas.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly and Co&nbsp;y su&nbsp;socio Incyte Corp&nbsp;dijeron este martes que resultados adicionales de un&nbsp;estudio&nbsp;en&nbsp;etapa avanzada&nbsp;mostraron&#8230;<\/p>\n","protected":false},"author":4,"featured_media":28935,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-28934","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-internacional"],"_links":{"self":[{"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/posts\/28934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/comments?post=28934"}],"version-history":[{"count":2,"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/posts\/28934\/revisions"}],"predecessor-version":[{"id":28986,"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/posts\/28934\/revisions\/28986"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/media\/28935"}],"wp:attachment":[{"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/media?parent=28934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/categories?post=28934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bambapolitica.com.mx\/index.php\/wp-json\/wp\/v2\/tags?post=28934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}